Pulmonx Corporation (LUNG) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin | 78.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 8.2M | FY2025-Q3 |
| New Zephyr Valve Treatment Centers Added in the United States | 12.00 | FY2025-Q2 |
Back to LUNG overview · LUNG earnings · LUNG holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.